Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium | 74 | 2023 | 371 | 11.280 |
Why?
|
| Muscle, Skeletal | 53 | 2023 | 383 | 9.130 |
Why?
|
| Calcium Signaling | 33 | 2018 | 112 | 6.180 |
Why?
|
| Sarcoplasmic Reticulum | 38 | 2017 | 158 | 4.870 |
Why?
|
| Calsequestrin | 13 | 2017 | 30 | 3.250 |
Why?
|
| Malignant Hyperthermia | 6 | 2023 | 18 | 3.160 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 25 | 2023 | 137 | 2.960 |
Why?
|
| Animals | 92 | 2023 | 3642 | 2.910 |
Why?
|
| Muscle Fibers, Skeletal | 21 | 2023 | 42 | 2.690 |
Why?
|
| Muscle Contraction | 16 | 2023 | 67 | 2.690 |
Why?
|
| Calcium Channels | 26 | 2019 | 112 | 2.100 |
Why?
|
| Caffeine | 12 | 2023 | 57 | 1.830 |
Why?
|
| Membrane Potentials | 31 | 2013 | 180 | 1.770 |
Why?
|
| Myocardium | 14 | 2017 | 101 | 1.720 |
Why?
|
| Muscles | 15 | 2006 | 58 | 1.660 |
Why?
|
| Myocytes, Cardiac | 8 | 2018 | 91 | 1.610 |
Why?
|
| Ion Channel Gating | 21 | 2017 | 187 | 1.570 |
Why?
|
| Hyperglycemia | 2 | 2023 | 29 | 1.480 |
Why?
|
| Microscopy, Confocal | 17 | 2013 | 88 | 1.450 |
Why?
|
| Rana pipiens | 31 | 2012 | 50 | 1.390 |
Why?
|
| Mice | 22 | 2022 | 1395 | 1.200 |
Why?
|
| Models, Biological | 21 | 2013 | 322 | 1.080 |
Why?
|
| Fluorescent Dyes | 7 | 2013 | 34 | 1.000 |
Why?
|
| Cytosol | 10 | 2012 | 42 | 0.890 |
Why?
|
| Glucose | 2 | 2023 | 49 | 0.870 |
Why?
|
| Halothane | 3 | 2023 | 11 | 0.860 |
Why?
|
| Cell Membrane | 8 | 2011 | 91 | 0.850 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 8 | 0.800 |
Why?
|
| In Vitro Techniques | 21 | 2012 | 175 | 0.770 |
Why?
|
| Computer Simulation | 5 | 2019 | 195 | 0.770 |
Why?
|
| Patch-Clamp Techniques | 20 | 2011 | 110 | 0.760 |
Why?
|
| Homeostasis | 3 | 2012 | 66 | 0.730 |
Why?
|
| Excitation Contraction Coupling | 3 | 2017 | 10 | 0.720 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2012 | 5 | 0.670 |
Why?
|
| Myocardial Contraction | 4 | 2015 | 38 | 0.660 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 50 | 0.620 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 127 | 0.620 |
Why?
|
| Calcium Channels, L-Type | 5 | 2015 | 52 | 0.610 |
Why?
|
| Muscular Diseases | 2 | 2015 | 13 | 0.600 |
Why?
|
| Microscopy, Fluorescence | 5 | 2022 | 79 | 0.600 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 22 | 0.580 |
Why?
|
| Cells, Cultured | 12 | 2018 | 520 | 0.580 |
Why?
|
| Electrophysiology | 19 | 2008 | 99 | 0.570 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 71 | 0.550 |
Why?
|
| Signal Transduction | 7 | 2018 | 443 | 0.550 |
Why?
|
| Cell Membrane Permeability | 4 | 2011 | 53 | 0.540 |
Why?
|
| Kinetics | 15 | 2013 | 188 | 0.500 |
Why?
|
| Action Potentials | 8 | 2013 | 86 | 0.490 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 27 | 0.480 |
Why?
|
| Biosensing Techniques | 2 | 2011 | 11 | 0.470 |
Why?
|
| Muscle Proteins | 2 | 2015 | 27 | 0.440 |
Why?
|
| Ryanodine | 2 | 2012 | 17 | 0.440 |
Why?
|
| Hypothermia | 1 | 2013 | 5 | 0.430 |
Why?
|
| Carrier Proteins | 2 | 2015 | 102 | 0.420 |
Why?
|
| Pyridinium Compounds | 1 | 2013 | 5 | 0.420 |
Why?
|
| Humans | 21 | 2023 | 27072 | 0.390 |
Why?
|
| Mutation | 4 | 2020 | 348 | 0.380 |
Why?
|
| Electric Stimulation | 12 | 2004 | 51 | 0.370 |
Why?
|
| Rats | 12 | 2016 | 664 | 0.360 |
Why?
|
| Protein Isoforms | 5 | 2022 | 44 | 0.350 |
Why?
|
| Neurons | 1 | 2012 | 339 | 0.330 |
Why?
|
| Rabbits | 10 | 2013 | 182 | 0.320 |
Why?
|
| Phenotype | 3 | 2020 | 312 | 0.300 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 13 | 0.290 |
Why?
|
| Central Nervous System Stimulants | 3 | 2000 | 41 | 0.290 |
Why?
|
| Protein Binding | 3 | 2019 | 126 | 0.290 |
Why?
|
| Algorithms | 7 | 2017 | 350 | 0.270 |
Why?
|
| Magnesium | 6 | 2012 | 35 | 0.270 |
Why?
|
| Mammals | 2 | 2023 | 25 | 0.270 |
Why?
|
| Ion Channels | 4 | 2009 | 223 | 0.240 |
Why?
|
| Sodium Compounds | 3 | 1993 | 4 | 0.240 |
Why?
|
| Perchlorates | 3 | 1993 | 5 | 0.240 |
Why?
|
| Phosphorylation | 4 | 2020 | 149 | 0.240 |
Why?
|
| Image Enhancement | 1 | 2005 | 48 | 0.240 |
Why?
|
| Neuromuscular Junction | 3 | 2009 | 8 | 0.240 |
Why?
|
| Kidney | 3 | 2003 | 153 | 0.240 |
Why?
|
| Membrane Proteins | 1 | 2006 | 165 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2018 | 333 | 0.230 |
Why?
|
| Heart | 3 | 2003 | 63 | 0.220 |
Why?
|
| Calcium Channel Blockers | 3 | 2010 | 31 | 0.220 |
Why?
|
| Heart Ventricles | 4 | 2013 | 92 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2010 | 301 | 0.210 |
Why?
|
| Egtazic Acid | 7 | 2011 | 12 | 0.210 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 13 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2007 | 332 | 0.210 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 13 | 0.210 |
Why?
|
| Tetracaine | 5 | 2007 | 8 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 39 | 0.200 |
Why?
|
| Anesthetics, Inhalation | 2 | 2020 | 12 | 0.200 |
Why?
|
| Adult | 6 | 2020 | 7831 | 0.190 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2002 | 4 | 0.190 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2002 | 10 | 0.190 |
Why?
|
| Anura | 5 | 2004 | 15 | 0.180 |
Why?
|
| Stomach Neoplasms | 1 | 2002 | 34 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2002 | 76 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 137 | 0.180 |
Why?
|
| Isoproterenol | 2 | 2013 | 13 | 0.170 |
Why?
|
| Phosphorylase Kinase | 1 | 2020 | 3 | 0.170 |
Why?
|
| Glycogen Phosphorylase, Muscle Form | 1 | 2020 | 3 | 0.170 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 3 | 0.170 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2013 | 16 | 0.170 |
Why?
|
| Glycogen | 1 | 2020 | 14 | 0.170 |
Why?
|
| Dihydropyridines | 3 | 1998 | 5 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2020 | 104 | 0.160 |
Why?
|
| Genotype | 1 | 2020 | 346 | 0.160 |
Why?
|
| Cytoplasm | 2 | 2013 | 37 | 0.150 |
Why?
|
| Time Factors | 5 | 2005 | 1433 | 0.150 |
Why?
|
| Species Specificity | 4 | 2005 | 42 | 0.140 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 1 | 0.140 |
Why?
|
| Synaptic Transmission | 2 | 1993 | 25 | 0.130 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1997 | 20 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2015 | 24 | 0.120 |
Why?
|
| Barium | 4 | 1998 | 13 | 0.120 |
Why?
|
| Electric Conductivity | 5 | 1997 | 70 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 41 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 164 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 599 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2009 | 143 | 0.120 |
Why?
|
| Ventricular Function | 2 | 1992 | 8 | 0.120 |
Why?
|
| Intracellular Membranes | 2 | 1991 | 21 | 0.120 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2010 | 17 | 0.110 |
Why?
|
| Male | 4 | 2018 | 14772 | 0.110 |
Why?
|
| Sodium Channels | 2 | 1992 | 13 | 0.110 |
Why?
|
| Fluorescence | 1 | 2013 | 9 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 381 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2011 | 22 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2012 | 42 | 0.100 |
Why?
|
| Binding Sites | 2 | 2009 | 73 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1992 | 5 | 0.100 |
Why?
|
| Protein Kinase C | 1 | 1992 | 48 | 0.100 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 14 | 0.100 |
Why?
|
| Cats | 1 | 2012 | 29 | 0.100 |
Why?
|
| Biophysical Phenomena | 2 | 2002 | 29 | 0.100 |
Why?
|
| Biophysics | 2 | 2002 | 35 | 0.100 |
Why?
|
| Nitrendipine | 1 | 1991 | 2 | 0.090 |
Why?
|
| Cell Line | 3 | 2003 | 273 | 0.090 |
Why?
|
| Mitochondria, Muscle | 1 | 2011 | 4 | 0.090 |
Why?
|
| Muscle Cells | 1 | 2011 | 12 | 0.090 |
Why?
|
| Sensory Receptor Cells | 1 | 1991 | 10 | 0.090 |
Why?
|
| Saponins | 2 | 2006 | 2 | 0.090 |
Why?
|
| Ligands | 1 | 2011 | 39 | 0.090 |
Why?
|
| Second Messenger Systems | 1 | 1991 | 5 | 0.090 |
Why?
|
| Xanthenes | 3 | 2000 | 4 | 0.090 |
Why?
|
| Aniline Compounds | 3 | 2000 | 35 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 195 | 0.090 |
Why?
|
| Buffers | 1 | 2010 | 11 | 0.090 |
Why?
|
| Female | 4 | 2020 | 15212 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 5 | 0.080 |
Why?
|
| Anesthetics, Local | 2 | 2003 | 80 | 0.080 |
Why?
|
| Metals, Alkali | 1 | 1989 | 1 | 0.080 |
Why?
|
| Metals, Alkaline Earth | 1 | 1989 | 1 | 0.080 |
Why?
|
| Feedback | 3 | 1997 | 33 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2009 | 33 | 0.080 |
Why?
|
| Gene Expression | 1 | 2010 | 199 | 0.080 |
Why?
|
| Middle Aged | 2 | 2020 | 8923 | 0.080 |
Why?
|
| Mitochondria | 1 | 2009 | 67 | 0.080 |
Why?
|
| Aged | 2 | 2020 | 8997 | 0.080 |
Why?
|
| Guinea Pigs | 3 | 1993 | 24 | 0.080 |
Why?
|
| Neutrophils | 1 | 2009 | 104 | 0.080 |
Why?
|
| Basophils | 1 | 2008 | 7 | 0.080 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 11 | 0.080 |
Why?
|
| Proton Pumps | 1 | 2008 | 14 | 0.080 |
Why?
|
| Chelating Agents | 2 | 2011 | 13 | 0.070 |
Why?
|
| Diffusion | 1 | 2008 | 24 | 0.070 |
Why?
|
| Lipid Bilayers | 4 | 2003 | 57 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2008 | 47 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 99 | 0.070 |
Why?
|
| Ranidae | 3 | 1991 | 3 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2007 | 8 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 15 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 34 | 0.070 |
Why?
|
| Biological Transport | 2 | 1999 | 39 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 474 | 0.070 |
Why?
|
| Markov Chains | 2 | 2002 | 33 | 0.060 |
Why?
|
| Thermodynamics | 2 | 2002 | 44 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 5 | 0.060 |
Why?
|
| Solutions | 1 | 2005 | 15 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2005 | 24 | 0.060 |
Why?
|
| Organelles | 1 | 2005 | 4 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 33 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 64 | 0.060 |
Why?
|
| Naphthalenesulfonates | 1 | 2004 | 1 | 0.060 |
Why?
|
| Phenolsulfonphthalein | 1 | 2004 | 1 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2004 | 14 | 0.060 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2003 | 14 | 0.060 |
Why?
|
| Electromagnetic Fields | 1 | 2003 | 9 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 47 | 0.050 |
Why?
|
| Rana catesbeiana | 2 | 2003 | 9 | 0.050 |
Why?
|
| Extracellular Space | 2 | 1996 | 11 | 0.050 |
Why?
|
| Oscillometry | 1 | 2002 | 5 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2002 | 127 | 0.050 |
Why?
|
| Probability | 2 | 1992 | 88 | 0.050 |
Why?
|
| Necrosis | 1 | 2002 | 26 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2002 | 54 | 0.050 |
Why?
|
| Fever | 1 | 2002 | 34 | 0.050 |
Why?
|
| Gallopamil | 2 | 1992 | 8 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2000 | 17 | 0.040 |
Why?
|
| Muscle Development | 1 | 1999 | 5 | 0.040 |
Why?
|
| Biomarkers | 2 | 2017 | 562 | 0.040 |
Why?
|
| Artifacts | 1 | 1999 | 30 | 0.040 |
Why?
|
| Benzopyrans | 2 | 2009 | 7 | 0.040 |
Why?
|
| Xenopus | 1 | 1998 | 4 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1998 | 27 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 29 | 0.040 |
Why?
|
| Diastole | 2 | 2010 | 28 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 36 | 0.040 |
Why?
|
| Base Sequence | 1 | 1998 | 109 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 156 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 120 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 195 | 0.040 |
Why?
|
| Pain | 1 | 2002 | 413 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 676 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 100 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 1998 | 310 | 0.040 |
Why?
|
| Spain | 1 | 2017 | 8 | 0.030 |
Why?
|
| Platelet Count | 1 | 2017 | 16 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2017 | 19 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2016 | 2 | 0.030 |
Why?
|
| Mannose | 1 | 2016 | 2 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 19 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2017 | 81 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 130 | 0.030 |
Why?
|
| Sodium | 2 | 1997 | 58 | 0.030 |
Why?
|
| Perfusion | 1 | 1996 | 17 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 102 | 0.030 |
Why?
|
| Rana esculenta | 1 | 1996 | 2 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 115 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 189 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 10 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 19 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 23 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 60 | 0.030 |
Why?
|
| Membranes | 1 | 1995 | 9 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 481 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 564 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 641 | 0.030 |
Why?
|
| Ion Transport | 1 | 1994 | 31 | 0.030 |
Why?
|
| Chlorides | 1 | 1994 | 25 | 0.030 |
Why?
|
| Cadmium | 1 | 1993 | 12 | 0.030 |
Why?
|
| Isradipine | 1 | 1993 | 2 | 0.030 |
Why?
|
| Calcium Radioisotopes | 1 | 1993 | 2 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 1993 | 3 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1993 | 3 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 9 | 0.030 |
Why?
|
| Cations | 1 | 1993 | 16 | 0.030 |
Why?
|
| Child | 1 | 2017 | 1295 | 0.030 |
Why?
|
| Transfection | 2 | 2007 | 121 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 6 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1992 | 13 | 0.030 |
Why?
|
| Mathematics | 1 | 1991 | 31 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 23 | 0.020 |
Why?
|
| Ruthenium Red | 1 | 1991 | 7 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 1991 | 5 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 2172 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1991 | 24 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 1994 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 2 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 34 | 0.020 |
Why?
|
| Ruthenium Compounds | 1 | 2009 | 2 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2009 | 2 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 4 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 18 | 0.020 |
Why?
|
| Naphthols | 1 | 2009 | 3 | 0.020 |
Why?
|
| Rhodamines | 1 | 2009 | 4 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 7 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 1989 | 3 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2009 | 48 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1991 | 644 | 0.020 |
Why?
|
| Protons | 1 | 2009 | 97 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 5 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 10 | 0.020 |
Why?
|
| Histamine | 1 | 2008 | 7 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 12 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 36 | 0.020 |
Why?
|
| Zinc | 1 | 2008 | 42 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3485 | 0.020 |
Why?
|
| Colforsin | 1 | 2007 | 12 | 0.020 |
Why?
|
| Benzylamines | 1 | 2007 | 10 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2007 | 11 | 0.020 |
Why?
|
| Calmodulin | 1 | 2007 | 8 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2007 | 37 | 0.020 |
Why?
|
| Peptides | 1 | 2007 | 102 | 0.020 |
Why?
|
| Heart Failure | 1 | 2007 | 151 | 0.010 |
Why?
|
| Potassium | 1 | 2003 | 62 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 79 | 0.010 |
Why?
|
| Calibration | 1 | 2002 | 20 | 0.010 |
Why?
|
| Biotransformation | 1 | 1997 | 6 | 0.010 |
Why?
|
| Myofibrils | 1 | 1988 | 6 | 0.000 |
Why?
|